Article Listing - Ligand's Panretin approved by FDA

FROM A RESEARCH-LED TO A MARKET-DRIVEN FIRM

23 March 1992

The task ofpharmaceutical industry management is to achieve the best possible balance between the constant pull of the market...

MORE EXPANSION AT CHILE'S LABS SAVAL

23 March 1992

Laboratorios Saval of Santiago in Chile, which is the third largest drugmaker in the ranking compiled by the national and...

CHILE'S PROFARMA SEEKING DEALS

23 March 1992

Laboratorios Profarma is one of Chile's smaller national pharmaceutical companies, but its size is not indicative of its importance in...

UK REGULATIONS ON HIV TESTING

23 March 1992

New regulations by the UK government aimed at controlling the sale and use of HIV testing kits will come into...

COMPARATIVE STUDY CALL WITH ZOFRAN

23 March 1992

Glaxo's 5-HT3 receptor antagonist anti-emetic Zofran (ondansetron) represents a great improvement on earlier anti-emetics for chemotherapy regimens that include cisplatin,...

MEDEVA ACQUIRES HEP-B PRODUCTS

23 March 1992

UK pharmaceuticals group Medeva is continuing its program of buying and developing pharmaceutical products with short development times with the...

SOMATOGEN'S rhB1.1 BLOOD SUBSTITUTE

23 March 1992

A collaborative research project between Somatogen and the UK Medical Research Council's Laboratory of Molecular Biology, Cambridge, has published a...